AIRNA
Signal active
Organization
Contact Information
Overview
AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments.
About
Industries
Biotechnology, Health Care, Medical
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
AIRNA headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $2.2B in funding across 24 round(s). With a team of 11-50 employees, AIRNA is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - AIRNA, raised $60.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
5
Lead Investors
0
Total Funding Amount
$90.0M
Details
2
AIRNA has raised a total of $90.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 30.0M | ||
| 2024 | Early Stage Venture | 60.0M |
Investors
AIRNA is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sean Kendall | - | FUNDING ROUND - Sean Kendall | 60.0M |
| Keith Crandell | - | FUNDING ROUND - Keith Crandell | 60.0M |
| AIRNA | - | FUNDING ROUND - AIRNA | 60.0M |
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 60.0M |
Recent Activity
There is no recent news or activity for this profile.